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ABSTRACT The control of pyrimidine biosynthesis in a yeast mutant deficient
for uracil, adenine, and histidine has been studied in vivo. The uracil mutation
causes accumulation of ureidosuccinic acid and dihydroorotic acid in the cells.
Accumulation is prevented when the pyrimidine nucleotide level in the cell is
raised, apparently owing to feedback inhibition in the pyrimidine system. Inves-
tigation of the coupling of purine and pyrimidine systems shows that a high level
of purine nucleotides can reverse inhibition in the pyrimidine internal feedback
loop. Under certan conditions this reversal may affect only the first step of the
pyrimidine system so that ureidosuccinic acid is synthesized and the next element
of the pyrimidine pathway, dihydroorotic acid, is not synthesized. Other aspects
of coupling between the pyrimidine system and other systems are presented.
INTRODUCTION
This paper' presents a study of regulation of pyrimidine synthesis and the relations
of this to purine and protein synthesis in a Saccharomyces cerevisiae haploid strain
with genetic blocks in the purine, pyrimidine, and histidine pathways. The pyrimi-
dine block is the result of a mutation to uracil deficiency and provides two special
advantages. First, that part of the pyrimidine biosynthetic pathway preceding the
block is intact and the pathway rate of synthesis can be estimated from the rate of
accumulation of the terminal products of the intact path, ureidosuccinate and
dihydroorotate. Secondly, manipulation and specific labeling of the pyrimidine
nucleotides do not depend on maintaining a level of these high enough to cut off
or spare internal synthesis of pyrimidines, so that low steady-state nucleotide levels
can be maintained, measured, and correlated with other cellular activities.
In the first paper of this series (1) the characteristics of feedback control of
purine synthesis in the cell were described. The same type of analysis is now applied
to pyrimidine synthesis, with the important addition of a study of coupling of the
1The second of the series on Regulation and coordination of purine and pyrimidine biosynthesis
in yeast.
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two pathways. The mutual regulation of the pathways is not symmetrical. The
purine system exerts greater control over the pyrimidine system than the latter does
on the former, and the details of this will be presented.
METHODS AND MATERIALS
The yeast strain employed in these studies is S1237A, developed and given to us by Dr.
R. K. Mortimer (University of California, Berkeley). It is a haploid Saccharomyces
cerevisiae containing three separately induced and independent biochemical deficiency
mutations combined into the one strain. The genotype is ur1 ad2his8; the colonies become
red in the absence of adenine. The uracil requirement is satisfied by uracil or uridine but
not by uridylate, UDP, cytidine, cytidylate, thymine, thymidine, or orotate. The adenine
requirement is satisfied by adenine or hypoxanthine but not by adenosine, adenylate,
ADP, guanine, guanosine, deoxy derivatives of the above, aminoimidazole carboxamide
(AICA), or AICA-riboside. The ur, allele causes loss of the enzyme dihydroorotate
dehydrogenase (2).
Cells were harvested in log phase (107 cells/ml) after hundredfold growth in synthetic
medium2 capable of supporting growth to 2 X 108 cells/ml. Only at concentrations
above 108 cells/ml were protein and RNA synthetic rates per cell decreased. These
rates were constant in the range 10' to 108 cells/ml, indicating that cells in this range
were not adapting to stationary phase. In experiments on regulation where growth was
permitted the cell concentration never exceeded 2 x 107 cells/ml. Cells were harvested
by centrifugation or membrane filter and immediately resuspended in preheated and
preaerated synthetic medium. No difference in effect of fresh or used synthetic medium
was found with respect to purine and pyrimidine synthesis, so fresh medium was used
ordinarily. Incubation was always at 30°C with aeration.
Assays of US (ureidosuccinic acid) and DHO (dihydroorotic acid) were made by
using the method of Gerhart and Pardee (3). This method allows specific determination
of US. DHO is determined by opening the ring with alkaline hydrolysis and assaying
the US thus formed. The method is accurate to 5% or better. US and DHO are ex-
tracted from cells in hot water (6 min at 90°C) and interfering compounds like citrulline
are removed from the extract by passing through a small Dowex 50 column (Dow
Chemical Co., Midland, Michigan) before assay.
In studies of the uptake of uracil-C1' the compounds receiving the label were separated
into the usual two fractions, the acid-soluble pool (SP) and the acid-insoluble pool
(IP). The acid-soluble compounds were extracted in cold 5% TCA for 1 hr, followed
by TCA wash. Alternatively, this pool was extracted in 95% ethanol for 3 min at 500C,
followed by extraction in 50% ethanol for 3 min at 50°C. The two methods give
identical results. The insoluble residues of extraction were collected on membrane filters.
The activity of the soluble fraction was calculated by substracting the activity of the
insoluble fraction from whole cell activity or by direct assay. Details of the membrane
filter method have been given (1).
2Synthetic medium composition: Vitamins, dextrose, trace elements, and salts, as in Difco
(Difco Laboratories, Detroit, Michigan) bacto yeast morphology agar with these exceptions:
Inositol, 2 ug/liter; K2HPO4, 5.3 gm/liter; KH2/PO4, 2.6 gm/liter. Substitutions: Ammonium
sulfate, 5 gm/liter; L-tryptophan, 0.2 gm/liter; 1-glutamate, 0.2 gm/liter; 1-methionine, 0.2 gm/
liter; 1-tyrosine, 0.25 gm/liter; cysteine, 0.2 gm/liter. Additions: Adenine and uracil, 50,ug/ml;
histidine, 200 ug/ml.
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For aspartate-C" uptake studies, separation of the individual C4-labeled compounds
is accomplished by chromatography on Gelman ITLC silica gel paper (Gelman Instru-
ment Company, Ann Arbor, Michigan) (4). By using phenol-H2O as solvent, a clear
separation of the main labeled components, asparate, glutamate, US, and DHO, is
obtained in 50 min. Identification of these components was made by the aid of two-
dimensional chromatography on large sheets of Whatman paper (H. Reeve Angel & Co.,
Clifton, New Jersey) and by the use of the method of Smith (5). Quantitative meas-
urement of activity of the components was made by using a Vanguard 880 strip
scanner and integrator (Vanguard Instrument Corp., Long Island, New York).
RESULTS
Identification and Assay of Pyrimidine Intermediates Accumulating as the
Result of the Uracil Deficiency Mutation. In one approach to identification of
intermediates, cells grown in synthetic medium were then incubated several hours
in the absence of uracil and harvested in gram quantities. Cells were then extracted
first in ether and then in 66% ethanol. Extracts were chromatographed by the
descending method, using either propanol-water solvent or butanol-ethanol-formic
acid-water (BEF) solvent. The extracts were run alone with orotic acid, dihydro-
orotic acid, and ureidosuccinic acid standards. The dried chromatograms were
photographed under ultraviolet light. With this method 5 or 10 ,ug of orotic acid
could be detected as an ultraviolet-absorbing spot. A number of ultraviolet-absorbing
spots appeared on chromatography of the extract, and a few of these had Rf's near,
but not identical with, that of orotic acid. These spots were eluted, and ultraviolet
absorption spectra were obtained from them. Since none of the spectra showed an
absorption peak in the neighborhood of 280 mu (orotic acid has a distinguishing
absorption peak at this wavelength), it was concluded that orotic acid does not
accumulate. The same amount of extract did, however, give rise to ultraviolet-
absorbing spots having the same Rf as DHO and US. These results are in agreement
with Lacroute's (2) demonstration that the ur, mutation in yeast leads to loss
of the enzyme DHO-dehydrogenase which converts DHO to orotic acid.
In order to add to the specificity of our identification of US and DHO and to
provide a method of quantitative estimation of these compounds, we adapted a
method of carbamylamino analysis, first described by Koritz and Cohen and im-
proved by Gerhart and Pardee (3). This colormetric method is specific for car-
bamylamino. The proportions of US and DHO in the mixture can be determined
without separation of the two because US gives a positive carbamylamino test
directly, whereas DHO must be hydrolyzed in 0.5 N alkali before it will give a
positive test. Identification and quantitative estimation were combined in the follow-
ing experiment. Two aliquots of nonproliferating cell suspension were incubated in
identical fashion in complete medium, except that aliquot A lacked uracil but had
adenine and aliquot B lacked adenine but had uracil. Application of the carbamy-
lamino test to crude extracts from these aliquots showed twice as much carbamy-
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lamino per A cell as per B cell. Purified extracts showed five times as much
carbamylamino in A as in B. Paper chromatography of the equivalent amounts of
extract from each aliquot was accomplished in BEF solvent. All extracts and
standards were run in duplicate. One of each pair was saved for later elution, and
the other was sprayed with DMAB (p-dimethyl-aminobenzaldehyde). DMAB, 2 g
in 20 ml concentrated HCI and 200 ml ethanol, gives a yellow color reaction with
carbamylamino compounds or indoles. The A aliquot gave strong positive DMAB
tests; one spot had the same Rf as US and the other the same Rf as DHO. The B
aliquot showed very faint spots slightly behind US and DHO standards. The posi-
tion of the spots and the sprayed strips of the chromatogram were used as a guide
for the elution of adjacent areas in the unsprayed strips. Amounts of US and DHO
in the eluants were then estimated (Table I).
TABLE I
Aliquot DHO/108 cell US/108 cell
ug ug
A 57 71
B 4.6 4.2
A similar procedure was used to develop chromatograms in phenol-water solvent.
In this solvent the relative Rf's of US and DHO are reversed, in contrast to the order
in BEF solvent. The results were similar to those obtained in BEF solvents.
The above results confirm that DHO and US accumulate only in the absence of
uracil. The identity of US and DHO is strongly supported by the fact that compounds
from A aliquot having the appropriate Rf's of US and DHO in two different solvent
systems appear. These compounds show a positive reaction in the Koritz and Cohen
test specific for carbamylamino.
Accumulation of US and DHO in Cells and Inhibition by Uracil. Log
phase cells grown in presence of uracil and adenine were put in media containing
varying proportions of uracil and adenine and the US-DHO of the cells was deter-
mined every 10 or 15 min for the 1st hr. Results are as follows:
(a) In zero uracil with or without adenine, DHO and US begin to accumulate imme-
diately, i.e. time lag less than 10 min, and the amount per cell increases approxi-
mately linearly with time for the 1st hr.
(b) In 2 ug/ml uracil or more (less was not tried at this time) DHO and US do
not accumulate.
It is noteworthy that detectable quantities of US and DHO do not appear in the
medium during the first couple hours of incubation in the absence of uracil. This,
coupled with the observation that the rate of accumulation is constant during this
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time, suggests that rate of accumulation is equivalent to rate of production. Fig. 1
shows the results of an experiment in which cells at time zero were transferred from
log phase growth in medium containing adenine and uracil to medium containing
no adenine and either 10 jug/ml uracil or none. In the absence of uracil, US and
DHO accumulate at constant but different rates. In the presence of uracil the pro-
duction of US and DHO is inhibited. The effects are readily reversible: production
of US and DHO is rapidly resumed when uracil is removed, and stopped when uracil
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FIGURE 1 Accumulation of ureidosuccinic acid (US) and dihydroorotic acid (DHO)
in cells exposed to concentrations of uracil (ur) and adenine (ad) as marked on the
graph. The figures in parentheses give concentration in micrograms per milliliter.
is added. Under the conditions of growth employed here the uracil moiety is
metabolized to pyrimidine nucleotides and thence to RNA. Inhibition is presumably
caused by one or more of these compounds. This has been established for Escherichia
coli (6). Experiments to establish this in vivo and to determine the effects of
coupling to the purine pathway on control in the pyrimidine pathway were next
undertaken.
Dependence of Synthesis of the Pyrimidine Intermediates US and DHO
on Pyrimidine and Purine Pools. In the yeast S1237 the pyrimidine ring of
pyrimidine nucleotides is derived only from the uracil supplied in the medium. If
C14-uracil is supplied, all pyrimidine nucleotides will be labeled and if this labeling
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is continued until constant or steady-state activity is obtained in the pyrimidine
pool, then each pyrimidine will have the same specific activity as the applied uracil
(7). Under these conditions the total amount of pyrimidine nucleotides is propor-
tional to the activity of the pool and only activity measurements need be made to
determine amount.
Fig. 2 shows the uptake of labeled uracil in the presence of adenine. The cells
were not depleted of uracil beforehand. SP and IP have similar meanings as in the
adenine work (1): SP is the cold TCA-soluble pool of uracil derivatives; IP is the
insoluble or nucleic acid pool. The SP uptake curve is quite different from that of
adenine C.14 Although the SP must contain the precursors of the IP, the rate of
turnover of the SP is apparently so hiigh that the IP already has much more activity
at 30 min than the SP. The pyrimidine SP continues to expand in the presence of
adenine long after the purine SP in the presence of uracil would reach steady state.
Another difference is that the rate of uptake of uracil into the IP increases as
external uracil concentration is increased in the range of 2 to 10 jug/ml and that the
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FIGURE 2 Incorporation of uracil-C1 into soluble (SP) and insoluble (IP) pools in
the cells. Incubation with 5 ,ug/ml uracil-C1 and 5 /Ag/ml adenine.
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SP also expands with uracil concentration as well as with time. The level of the
pyrimidine SP when fed with uracil in the presence of adenine is apparently not
sharply limited, in contrast to the purine case.
In later work it was found possible to obtain a steady-state pyrimidine SP by
incubating cells with 20 jug/ml uracil-C'4 and zero adenine. Fig. 3 shows the latter
part of the SP uptake curve under these conditions. The steady state in 0 adenine
is reached in about 90 min. If adenine is added (1.5 or 5 jtg/ml) at 90 min, the
pyrimidine SP is depressed and comes to a lower steady-state level which persists.
The depression of the pyrimidine SP is more rapid the higher the external concen-
trations of adenine, corresponding inversely to the increase in purine SP (1). With
1.5 ug/ml adenine added, the steady state is terminated at 140 min owing to the
exhaustion of adenine from the medium, and the SP rises. It rises well beyond the
value it would have if the cells had been in zero adenine uninterruptedly (overshoot).
Exposure to adenine apparently increases the capacity of the pyrimidine SP or
temporarily decreases self-regulation, although as long as the adenine SP is high
(until 140 min), this regulates the pyrimidine SP level.
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FIGuRE 3 Intracellular pyrimidine soluble pool, measured in counts per minute vs.
time. Cells were incubated with 20 ,ug/ml uracil-Cl without adenine until 90 min;
then 0, 1.5, or 5 /Ag/ml adenine was provided, as indicated on the graph.
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Absence of uracil, which leads to depression of pyrimidine SP, decreases feedback
inhibition of attempted pyrimidine synthesis and leads to accumulation of DHO and
US. We now ask: Does lowering the pyrimidine SP by purine manipulation in the
presence of excess uracil also release feedback inhibition? Fig. 4 shows the behavior
of US synthesis in an experimental situation exactly the same as in Fig. 3. The
lower curve shows the results of incubation in 20 ,ug/ml uracil and zero adenine.
In zero uracil and zero adenine there is no feedback inhibition of US synthesis
(Fig. 1). In 20 jug/ml uracil and zero adenine, US synthesis is completely sup-
pressed; the corresponding curve of Fig. 3 shows the pyrimidine SP to be high and
constant after 90 min. The upper curve shows what happens when 5 jug/ml adenine
is added at 90 min to cells prepared in 20 jug/ml uracil and zero adenine. First
there is a lag of 35 min during which no effect of adenine on US synthesis is seen.
During this time pyrimidine SP drops (Fig. 3) and purine SP rises (1) concurrently.
At 125 min, US begins to accumulate at a rate close to that of the zero uracil
control (Fig. 1). Control of pyrimidine synthesis by uracil has been counteracted
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FIGURE 4 Ureidosuccinic acid (US) level in cells incubated with 20 ,ug/ml uracil
(no adenine) until 90 min, after which 0 or 5 jAg/ml adenine was added as indicated
on the graph. Uracil and adenine concentrations in the medium are not substantially
altered by cellular uptake during the time period covered in the graph.
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although excess uracil is present and the rate of transfer of uracil into the cells,
through the SP, and into the nucleic acids has not been decreased.
Fig. 5 shows the behavior of DHO in the same experimental situation as in Figs.
3 and 4. In 20 jug/ml uracil and zero adenine, DHO synthesis is completely sup-
pressed; in zero uracil and zero adenine it is synthesized at a constant high rate
(Fig. 1). Thus far the control of DHO is like that of US. However, when 5 ,ug/ml
adenine is added at 90 min (Fig. 5), it can be seen that DHO does not begin to
accumulate again. This is in contrast to the US case. Hence, adenine, through the
influence of purine derivatives formed from it (1), can counteract the feedback
inhibition of US synthesis but it does not at the same time allow the conversion of
US to DHO to resume. In cells not having a mutant block in the pyrimidine pathway
this control mechanism would allow storage of the specific pyrimidine precursor
US under certain conditions of excess purine and pyrimidine nucleotide supply.
If the cells undergo preliminary incubation in complete medium containing
50 jg/ml adenine and uracil and are transferred to 10 ttg/ml adenine and uracil
or 10 jug/ml uracil and 3 jug/ml adenine, a different result is obtained. In this case
both US and DHO begin to accumulate immediately. US continues to accumulate
at least for 1 hr, but DHO accumulation may stop after 30 min or so. Hence the
type of response the pyrimidine system makes to shifts in the purine system clearly
depends on the states of both systems at the time of shift.
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FIGURE 5 Dihydroorotic acid (DHO) level in cells incubated with 20 ,ug/ml uracil
without adenine until 90 min; then 0 or 5 ug/ml adenine was added as indicated on
the graph.
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Since the pyrimidine pathway is coupled to other biosynthetic pathways, it be-
comes of interest to ask what indirect effects may be produced by turning pyrimidine
synthesis off and on. A direct and immedate precursor of US is aspartate which is
also a precursor of various amino acids such as threonine, methionine, lysine,
arginine, etc., and of protein. Since aspartate enters the pyrimidine pathway slowly
or not at all when the pathway is inhibited by supplying uracil to the cells, it might
accumulate or be diverted to other syntheses in greater quantity. To facilitate
determination of the fate of aspartate carbon a tracer method employing uniformly
labeled C14-asparatate was used. The cells take up aspartate readily although they
do not require it. The cold TCA or 50% ethanol extract of aspartate-C'4-labeled
cells contains the small molecules for which aspartate is a precursor. The only ones
exhibiting substantial incorporation of activity have been identified by means of
silica gel-glass fiber chromatography as aspartate, glutamate, US, and DHO. The
activities of these in samples taken at various times can be measured in a radio-
activity scanning and measuring device. The ethanol insoluble activity is contained
in protein which has incorporated C14-aspartate, C14-glutamate, and perhaps other
indirectly labeled amino acids.
The most illuminating experiments of many performed involved the incubation
of cells with C14-aspartate and 50 ug/ml adenine for 150 min without uracil, at
which time 20 jug/ml uracil is added. Fig. 6 shows the behavior of the labeled
aspartate and glutamate pools. These pools increase slowly in the absence of uracil
but the rates of increase nearly double soon after uracil is added, presumably
reflecting decreased consumption of aspartate in attempted pyrimidine synthesis.
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FiGURE 6 Changes in labeled free aspartate and glutamate pools with time. Cells
were incubated with Cl4-aspartate and adenine at essentially constant levels until 150
min, after which 20 jug/ml uracil was supplied. Ordinate: 10' ,uc per cell.
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Since more aspartate would then be available for protein synthesis and the provision
of uracil to cells starved 150 min for pyrimidines might be expected to enhance
messenger RNA synthesis, one might expect increased protein synthesis. Measure-
ments of C'4 incorporation into the insoluble pool indeed showed this. The rate
of incorporation was constant at 1200 cPM/hr before uracil addition and for about
10 min after, at which time it increased sharply to a new constant value of 2250
cPM/hr. The introduction of uracil then approximately doubled the incorporation
rate and presumably doubled the rate of protein synthesis.
This same experiment allowed an independent check, under somewhat different
conditions than those used previously, of the differential feedback control of US and
DHO synthesis when both purine and pyrimidine nucleotides are present in the
cells. Fig. 7 shows the activities of US and DHO as a function of time. These increase
steeply before uracil addition as a result of the rapid synthesis and accumulation
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FIGURE 7 Changes in labeled US and DHO pools with time. Cells were incubated
with C"4-aspartate and adenine until 150 min, whereupon 20 ,g/ml uracil was added.
Ordinate: 10-' jAc per cell.
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of these compounds. After uracil addition US continues to accumulate at a slightly
reduced rate, but the accumulation of DHO is virtually stopped. US, of course,
would also be stopped if no adenine were supplied to the cells. Clearly there is
differential control of US and DHO synthesis, similar to that illustrated in Figs. 4
and 5. In that case adenine was added to cells deprived of it but consistently supplied
with uracil, whereas in the present case the starvation and addition regime were
vice versa.
DISCUSSION
The synthesis of US and DHO in S1237 can be turned off and on rapidly through
variation of uracil concentration outside the cells and the resultant change in in-
ternal pyrimidine nucleotide levels. Since this is rapid, it must involve control of
enzyme activity rather than amount although control through repression and
derepression presumably exists. End-product inhibition in the pyrimidine pathway
has been demonstrated in other systems, notably in Escherichia coli and lettuce
(3, 8). In these systems the site of feedback control appears to be the enzyme
aspartate transcarbamylase. In Escherichia coli the most effective end-product in-
hibitor is cytidine triphosphate; in lettuce it is uridine monophosphate. Although
we have not been able to extract active aspartate transcarbamylase from the yeast
for in vitro studies, the data presented from in vivo studies strongly suggest that
this enzyme is controlled by feedback inhibition in yeast.
The demonstration that increasing the level of the purine nucleotide pool by
applying adenine counteracts feedback inhibition in the pyrimidine pathway raises
questions of mechanism. First of all it is noted that the over-all level of the pyrimidine
nucleotide pool decreases when the purine pool level is increased. Decreasing the
pyrimidine level in this way then might reverse feedback inhibition. However, US
and DHO syntheses can be differentially affected by purine counteraction but not
by manipulation of the pyrimidine level through adjustment of uracil concentra-
tion. If the purine effect takes place through the pyrimidine pool we must then
postulate that the composition of the pool is different when lowered by purines
than by uracil and that the enzymes aspartate transcarbamylase and dihydroorotase
are inhibited by different pyrimidine nucleotides. An alternate explanation can
be based on the demonstration (9) that ATP can reverse the CTP inhibition of
aspartate transcarbamylase obtained from Escherichia coli. If the yeast enzyme
responds the same way, then the purine reversal effect may be the result of ATP
level increasing when adenine is added and the ATP then acting directly on the
transcarbamylase. This explanation requires no action of ATP on dihydroorotase.
It is noteworthy that the effect of purines on the pyrimidine pathway is not recipro-
cal; that is, we cannot counteract purine end-product inhibition of the purine path-
way by application of uracil to the cell system (1).
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In Fig. 3 it was noted that application of adenine to cells in excess uracil with
subsequent exhaustion of adenine produces an expansion of the pyrimidine pool
beyond what it would have if adenine had never been applied. This "overshoot"
behavior is hard to explain on the basis of our present knowledge of the dynamics
of the system. A possibility is that the overshoot is the result of pyrimidines col-
lecting in a storage pool (10) which can hold more pyrimidine after the cells
have grown in the presence of adenine.
The demonstration that the synthesis of US can occur under certain conditions
of feedback balance between the pyrimidine and purine pools while at the same
time synthesis of DHO is inhibited reveals a new type of control mechanism. The
utility of this mode of control for the cell would be that under conditions of
temporary pyrimidine excess a store of precursor that can only be used for
pyrimidine synthesis is built up. Aspartate stores would not guarantee pyrimidine
synthesis in times of low aspartate production since this compound is also used for
protein synthesis. Lacroute (2) has reported that in yeast US can induce the
enzyme dihydroorotase that converts US to DHO. This slow control mechanism
(involving enzyme formation) presumably would act to set an upper limit to the
pool of US that could be accumulated. Production of US and not DHO when
both uracil and adenine are present does not always occur. When the cells undergo
no preliminary starvation for either purine or pyrimidines, both US and DHO may
be synthesized.
Observation of the metabolism of aspartate as affected by manipulation of the
purine and pyrimidine pools reveals some of the characteristics of weak coupling
(11) among pools. When there is an ample supply of purines and pyrimidines,
which provide raw material for M-RNA synthesis, aspartate is diverted to protein
synthesis, and pools of protein raw materials like aspartate itself and glutamate
begin to grow.
The author wishes to thank Kersten Fredericks and Daniel Wong for excellent technical as-
sistance in different phases of this work.
The research was supported by Research Grant AM 09434 from the National Institutes of
Health.
Received for publication 9 May 1966.
REFERENCES
1. BURNS, V. W., Biophysic. J., 1964, 4, 151.
2. LACROUTE, F., Compt. rend., 1964, 258, 2884.
3. GERHART, J. C., and PARDEE, A. B., J. Biol. Chem., 1962, 237, 891.
4. BURNS, V. W., and WONG, D., J. Chromatography, in press.
5. SMrrH, I., Chromatographic and Electrophoretic Techniques, New York, Interscience Pub-
lishers, 1, 1960.
6. YATEs, R., and PARDEE, A. B., J. Biol. Chem., 1956, 221, 757.
VIcrOR W. BuRNs Pyrimidine Biosynthesis 799
7. BASSHAM, J., and KmK, M., in Rapid Mixing and Sampling Techniques in Biochemistry,
(B. Chance, editor), New York, Academic Press Inc., 1964, 319.
8. NEUMAN, J., and JONES, M. E., Nature, 1962, 195, 709.
9. GERHART, J. C., and PARDEE, A. B., Fed. Proc., 1964, 23, 727.
10. MCCARTHY, B. J., and BRrrTEN, R. J., Biophysic. J., 1962, 2, 35.
11. GOODWIN, B. C., Temporal Organization in Cells, New York, Academic Press Inc., 1963.
800 BIOPHYsIcAL JouRNAL VOLUME 6 1966
